Journal
FASEB JOURNAL
Volume 20, Issue 11, Pages 1898-+Publisher
WILEY
DOI: 10.1096/fj.06-5898fje
Keywords
epithelial-mesenchymal transition; chronic kidney disease; tubular atrophy; interstitial fibrosis
Categories
Funding
- NIDDK NIH HHS [K08 DK 59383, R01 DK39776] Funding Source: Medline
Ask authors/readers for more resources
Chronic kidney disease (CKD) and failure are problems of increasing importance. Regardless of the primary etiology, CKD is characterized by tubular atrophy, interstitial fibrosis, and glomerulosclerosis. It has been assumed that diminished matrix metalloproteinase (MMP) activity is responsible for the accumulation of the extracellular matrix (ECM) proteins and collagens that typify the fibrotic kidney. Here we demonstrate that transgenic renal proximal tubular epithelial expression of a specific enzyme, MMP-2, is sufficient to generate the entire spectrum of pathological and functional changes characteristic of human CKD. At the earliest point, MMP-2 leads to structural alterations in the tubular basement membrane, a process that triggers tubular epithelial-mesenchymal transition, with resultant tubular atrophy, fibrosis and renal failure. Inhibition of MMP-2, specifically in the early, prefibrotic stages of disease may offer an additional approach for treatment of these disabling disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available